1. Home
  2. GHLD vs CDNA Comparison

GHLD vs CDNA Comparison

Compare GHLD & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHLD
  • CDNA
  • Stock Information
  • Founded
  • GHLD 1960
  • CDNA 1998
  • Country
  • GHLD United States
  • CDNA United States
  • Employees
  • GHLD N/A
  • CDNA N/A
  • Industry
  • GHLD Finance: Consumer Services
  • CDNA Medical Specialities
  • Sector
  • GHLD Finance
  • CDNA Health Care
  • Exchange
  • GHLD Nasdaq
  • CDNA Nasdaq
  • Market Cap
  • GHLD 977.9M
  • CDNA 1.0B
  • IPO Year
  • GHLD 2020
  • CDNA 2014
  • Fundamental
  • Price
  • GHLD $19.82
  • CDNA $19.77
  • Analyst Decision
  • GHLD Hold
  • CDNA Buy
  • Analyst Count
  • GHLD 6
  • CDNA 6
  • Target Price
  • GHLD $16.30
  • CDNA $30.33
  • AVG Volume (30 Days)
  • GHLD 145.8K
  • CDNA 908.5K
  • Earning Date
  • GHLD 08-07-2025
  • CDNA 07-30-2025
  • Dividend Yield
  • GHLD 2.52%
  • CDNA N/A
  • EPS Growth
  • GHLD 63.18
  • CDNA N/A
  • EPS
  • GHLD 0.71
  • CDNA 1.07
  • Revenue
  • GHLD $1,131,796,000.00
  • CDNA $346,421,000.00
  • Revenue This Year
  • GHLD $5.64
  • CDNA $13.31
  • Revenue Next Year
  • GHLD $26.37
  • CDNA $15.46
  • P/E Ratio
  • GHLD $27.84
  • CDNA $17.91
  • Revenue Growth
  • GHLD 32.57
  • CDNA 25.92
  • 52 Week Low
  • GHLD $11.21
  • CDNA $14.09
  • 52 Week High
  • GHLD $20.15
  • CDNA $34.84
  • Technical
  • Relative Strength Index (RSI)
  • GHLD 81.49
  • CDNA 62.23
  • Support Level
  • GHLD $19.79
  • CDNA $18.37
  • Resistance Level
  • GHLD $20.02
  • CDNA $19.84
  • Average True Range (ATR)
  • GHLD 0.11
  • CDNA 0.78
  • MACD
  • GHLD -0.07
  • CDNA -0.00
  • Stochastic Oscillator
  • GHLD 32.65
  • CDNA 84.56

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: